Cannabis detected in follicular fluid altered epigenetic markers in surrounding egg cells
Among 318 follicular fluid samples from IVF patients, cannabis exposure increased cannabinoid receptor expression and reduced DNA methylation enzyme expression in granulosa cells, with cannabis detection rates tripling from 4% to 12% after Canadian legalization.
Quick Facts
What This Study Found
6.4% of patients tested positive for cannabis in follicular fluid. Cannabis positivity rose from 4% pre-legalization to 12% post-legalization. Only 59% of positive patients had reported cannabis use at intake. Cannabis exposure increased CB2 receptor expression in granulosa cells and reduced DNMT3b expression and global DNA methylation, effects sustained through chronic treatment in vitro.
Key Numbers
318 follicular fluid samples; 261 IVF patients; 17 (6.4%) positive for cannabis; prevalence rose 4% to 12% after legalization; 59% of positive patients self-reported use; CB2R expression increased; DNMT3b expression decreased; global DNA methylation decreased
How They Did This
Combined in vivo cohort (318 follicular fluid samples from 261 IVF patients, measured by LC-MS/MS) and in vitro validation using naive granulosa cells treated with phytocannabinoids. Flow cytometry assessed receptor and enzyme expression; ELISA measured global DNA methylation.
Why This Research Matters
Epigenetic changes in the cells surrounding developing eggs could affect oocyte quality and embryo development. The finding that cannabis alters DNA methylation in the follicular niche raises concerns about reproductive effects that may not be immediately apparent.
The Bigger Picture
As cannabis legalization increases access for women of reproductive age, the finding that cannabis alters epigenetic machinery in the ovarian follicle adds urgency to understanding whether these molecular changes translate to clinical reproductive outcomes.
What This Study Doesn't Tell Us
Small number of cannabis-positive patients (n=17). Could not assess clinical outcomes due to sample size. No details on consumption mode, frequency, or timing. IVF patients may not represent the general reproductive population. In vitro conditions differ from in vivo exposure.
Questions This Raises
- ?Do the observed epigenetic changes translate to impaired oocyte quality or embryo development?
- ?Are the effects reversible after cannabis cessation?
- ?How does the timing and dose of cannabis exposure affect the severity of epigenetic disruption?
Trust & Context
- Key Stat:
- Cannabis detection in follicular fluid rose from 4% to 12% after legalization
- Evidence Grade:
- Novel finding with both in vivo and in vitro validation, though limited by the small number of cannabis-positive patients and inability to assess clinical outcomes.
- Study Age:
- Published in 2021 using 2018-2019 IVF samples.
- Original Title:
- Cannabis alters epigenetic integrity and endocannabinoid signalling in the human follicular niche.
- Published In:
- Human reproduction (Oxford, England), 36(7), 1922-1931 (2021)
- Authors:
- Fuchs Weizman, Noga(3), Wyse, Brandon A(3), Szaraz, Peter, Defer, Miranda, Jahangiri, Sahar, Librach, Clifford L
- Database ID:
- RTHC-03139
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Does cannabis affect fertility?
This study found that cannabis exposure changed the molecular environment around developing eggs by increasing cannabinoid receptor expression and reducing DNA methylation. Whether these molecular changes affect actual fertility outcomes remains unknown and requires larger studies.
Did all patients report their cannabis use?
No. Only 59% of patients who tested positive for cannabis in their follicular fluid had reported use during their initial intake. This suggests self-reporting significantly underestimates actual cannabis exposure among fertility patients.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-03139APA
Fuchs Weizman, Noga; Wyse, Brandon A; Szaraz, Peter; Defer, Miranda; Jahangiri, Sahar; Librach, Clifford L. (2021). Cannabis alters epigenetic integrity and endocannabinoid signalling in the human follicular niche.. Human reproduction (Oxford, England), 36(7), 1922-1931. https://doi.org/10.1093/humrep/deab104
MLA
Fuchs Weizman, Noga, et al. "Cannabis alters epigenetic integrity and endocannabinoid signalling in the human follicular niche.." Human reproduction (Oxford, 2021. https://doi.org/10.1093/humrep/deab104
RethinkTHC
RethinkTHC Research Database. "Cannabis alters epigenetic integrity and endocannabinoid sig..." RTHC-03139. Retrieved from https://rethinkthc.com/research/fuchs-2021-cannabis-alters-epigenetic-integrity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.